Busca:    
 
 
English

 

Cemicamp
Caixa Postal 6181
Cep
13084-971
Campinas, SP, Brasil
fone (19) 3289-2856
cemicamp@cemicamp.org.br
veja como chegar

 

 

FERTILIDADE: ANTICONCEPÇÃO E INFERTILIDADE

Bahamondes, L; Nascimento, JAA; Munuce, MJ; Fazano, F; Faúndes, A. The in vitro effect of levonorgestrel on the acrosome reaction of human spermatozoa from fertile men. Contraception, 68(1):55-9, 2003.

Hassan, DF; Petta, CA; Aldrighi, JM; Bahamondes, L; Perrotti, M. Weigh variation in a cohort of women using copper IUD for contraception. Contraception, 68(1):27-30, 2003.
Faúndes, A; Brache, V; Alvarez, F. Emergency contraception – Clinical and ethical aspects. International Journal of Gynecology & Obstetrics,
82(2003):297-305.

Alvarez, F; Brache, V; Faúndes, A; Jorge, A; Sousa, MH. Local side effects observed among long-term users of Norplant contraceptive implants. Contraception, 68(2003):111-5.

Pedro, AO; Pinto Neto, AM; Paiva, LHSC; Osis, MJ; Hardy, E. Idade de ocorrência da menopausa natural em mulheres brasileiras: resultados de um inquérito populacional domiciliar. Cad Saúde Pública 19(1):17-25, 2003.

Hardy, E; Pádua, KS de; Hebling, EM; Osis, MJD; Zaneveld, LJD. Women’s preferences for vaginal antimicrobial contraceptives V: Attitudes of Brazilian women to the insertion of vaginal products. Contraception 67(5), 391-95, 2003.

Giacobbe, M; Zeferino, LC; Franzin, CM; Faundes, A.Uteroplacental circulation during the first trimester of normal and abnormal pregnancy. Reprod Biomed Online. 2002 Jan-Feb;4(1):62-7.

Pinto Neto, AM; Pedro, AO; Hardy, E; et al. Caracterização das usuárias de terapia de reposição hormonal do Município de Campinas, São Paulo. Cad Saúde Pública, Fev 2002, 18(1):121-7.

Torres, JC; Derchain, SF; Faundes, A; Montijo, RC; Martinez, EZ; Andrade, LA. Risk-of-malignancy index in preoperative evaluation of clinically restricted ovarian cancer. Sao Paulo Med J. 2002 May 2;120(3):72-6.

Guarisi, T; Pinto-Neto, AM; Herrmann, V; Faundes, A. Urodynamics in climacteric women with urinary incontinence: correlation with route of delivery. Int Urogynecol J Pelvic Floor Dysfunct. 2002;13(6):366-71.

Croxatto, HB; Fuentealba, B; Brache, V; Salvatierra, AM; Alvarez, F; Massai, R; Cochon, L; Faundes, A. Effects of the Yuzpe regimen, given during the follicular phase, on ovarian function. Contraception. 2002 Feb;65(2):121-8.

Brache, V; Faundes, A; Alvarez, F; Cochon, L. Nonmenstrual adverse events during use of implantable contraceptives for women: data from clinical trials. Contraception. 2002 Jan;65(1):63-74.

Johansson, E; Brache, V; Alvarez, F; Faundes, A; Cochon, L; Ranta, S; Lovern, M; Kumar, N. Pharmacokinetic study of different dosing regimens of levonorgestrel for emergency contraception in healthy women. Hum Reprod. 2002 Jun; 17 (6):1472-1476.
Nascimento, R; Bahamondes, L; Hidalgo, M; Perrotti, M; Espejo-Arce, X; Petta CA. User’s perspectives on bleeding patterns after two years of levonorgestrel-releasing intrauterine system use. Drugs RD. 2002; 3(6)387-91.

Monteiro, I; Bahamondes, L; Díaz, J; Perrotti, M; Petta, C. Therapeutic use of levonorgestrel releasing intrauterine system in women wih menorrhagia a pilot study(1). Contraception. 2002 May; 65(5):325-8

Hidalgo, M; Bahamondes, L; Perrotti, M; Díaz, J; Dantas-Monteiro, C; Petta, C. Bleeding pattern and clinical performance of the levonorgestrel-releasing intrauterine system (Mirena) up to two years. Contraception. 2002 Feb; 65(2):129-32

Makuch, MY; Hardy, E. Mother-child relationship after in vitro fertilization. Gynaecology Forum 2002; 7(4): 21-23.
Perrotti, M; Bahamondes, L. Use of levonorgestrel-releasing intrauterine system in women with menorragia: a review. Obs & Gynae Today, 7(10):615-619, 2002.

Pedro, AO; Pinto Neto, AM; Costa-Paiva, LHS; Osis, MJD; Hardy, E. Climateric woman seeking medical care, Brazil. Rev de Saude Pub 2002; 36(4):484-90.

Faúndes, A; Guarisi, T; Pinto-Neto, AM. The risk of urinary incontinence of parous women who delivered only by cesarean section. International Journal of Gynecology & Obstetrics, 72(2001) 41-46

Osis, MJD; Pádua, KS; Duarte, GA; Souza, TR; Faúndes, A. The opinion of Brazilian women regarding vaginal labor and cesarean section. International Journal of Gynecology & Obstetrics, 75(2001) S59-S66.

Guarisi, T; Pinto Neto, AM; Osis, MJ; Pedro, AO; Paiva, LHC; Faúndes, A. Incontinência. Urinária entre mulheres climatéricas brasileiras: inquérito domiciliar. Rev Saúde Pública; 35(5):428-35, 2001.

Bahamondes, L; Castillo, SD; Tabares, G; Arce, XE; Perroti, MA; Petta, CA. Comparison of weight increase in users of depot medroxyprogesterone acetate and copper IUD up to 5 years. Contraception, 64:223-225, 2001.

Brache, V; Mishell, DR; Lahteenmaki, P; Alvarez, F; Elomaa, K; Jackanicz, T; Faúndes, A. Ovarian function during use of vaginal rings delivering three different doses of NestoroneI. Contraception, 63(5):257-261, 2001

Brache, V; Alvarez, F; Faúndes, A. Mechanism of action of levonorgestrel contraceptive implants. Gynecol Endocrinol, 15(Suppl 2):14-20, 2001
Faúndes, Ver Planejamento familiar no Brasil. Jornal da FEBRASGO, 3:4-5, 2001
Faúndes, A; Ávila, B; Araújo, MJ. Relatório Final – Seminário “Implantes, DIU, Métodos de Barreira: Situação atual no Brasil, a luz da saúde e dos direitos sexuais e reprodutivos. Femina, 29(8):497-501, 2001.

Galvão, L; Díaz, J; Díaz, M; Osis, MJD; Clark, S; Ellertson, C. Anticoncepção de emergência: conhecimento, atitude e práticas entre ginecologistas-obstetras no Brasil. Perspectivas Internacionais em Planejamento Familiar, número especial: 20-3 e 45, 2001.

Hardy, E; Duarte, GA; Osis, MJD; Arce, XE; Possan, M. Anticoncepção de emergência no Brasil: facilitadores e barreiras. Cad Saúde Públ, 17(4):1031-1035, 2001.

Hardy, E; Duarte, GA; Osis, MJD; Espejo-Arce, X; Possan, M. Aceitabilidade da anticoncepção de emergência no Brasil. Femina, 29(10):717-720, 2001

Petta, CA; Hays, M; Brache, V; Massai, R; Hua, Y; Alvarez-Sánchez, F; Croxatto, H; d’Arcangues, C; Cook, LA; Bahamondes, L. Delayed first injection of the once-a-month injectable contraceptive containing 25 mg of midroxiprogesterone acetate and 5 mg of E2-cypionate: effects on ovarian function. Fertil and Steril, 75(4):744-748, 2001

Petta, CA;Hays, M; Brache, V; Massai, R; Hua, Y; Alvarez-Sánchez, F; Croxatto, H; d’Arcangues, C; Cook, LA; Bahamondes, L. Delayed first injection of the once-a-month injectable contraceptive containing 25 mg medroxyprogesterone acetate and 5 mg estradiol-cypionate: effects on cervical mucus. Contraception, 64:363-368, 2001

Perrotti, MA; Bahamondes, L; Petta, CA; Castro, SRN. Forearm bone density in long-term users of oral combined contraceptives and depot medroxyprogesterone acetate. Fertility & Sterility, 76(3):469-473, 2001

Welkovic, S; Costa, LOBF; Faundes, A; de Alencar Ximenes, R; Costa, CF. Post-partum bleeding and infection after post-placental IUD insertion. Contraception, 63(3):155-158, 2001.

Alvarez-Sanchez, F; Brache, V; Montes de Oca, V; Cochon, L; Faúndes, A. Prevalence of enlarged ovarian follicles among users of levonorgestrel subdermal contraceptive implants (Norplant). Am J Obstet Gynecol, 182(3):535-539, 2000.

Bahamondes, L; Trevisan, M; Andrade, L; Marchi, NM; Castro, S; Diaz, J; Faúndes, A. The effect upon the human vaginal histology of the long-term use of the injectable contraceptive Depo-Provera®. Contraception, 62(1):23-27, 2000.

Bahamondes, L. Metabolic effects of injectable contraceptives. Gynaecology Forum, 5(1): 16-18, 2000.

Bassol, S; Alvarado, A; Celis, C; Cravioto, MC; Peralta, O; Montano, R; Novelli, J; Albornoz H, Kesseru E, Soares A, Petracco A, Isaia B, Mendes J, Bahamondes L, Melo NR, Reyes-Marques R, Albrecht G. Latin American experience with two low-dose oral contraceptives containing 30 mg ethinylestradiol / 75 mg, gestodene and 20 mg ethinylestradiol/150 mg desogestrel. Contraception, 62:131-135, 2000.

Biazotti, MCS; Martinez, EZM; Böttcher-Luiz, FA; Fazano, FA; Sene, IS; Lucio, M; Bahamondes, L. Influências das características do sêmen sobre os resultados de fertilização “in vitro”. Jornal Brasileiro de Reprodução Assistida, 4(1):11-18, 2000.

Brache, V; Alvarez-Sanchez, F; Faúndes, A; Jackanicz, T; Mishell, DR; Lahteenmaki, P. Progestin-only contraceptive rings. Steroids, 65:687-691, 2000.

Brache, V; Massai, R; Mishell, DR; Alfred, M; Alvarez, F; Salvatierra, AM; Cochon, L; Croxatto, H; Robbins, A; Faúndes, A. Ovarian function during use of Nestorone® subdermal implants. Contraception, 61:199-204, 2000.

Diaz, J; Bahamondes, L; Monteiro, I; Petta, C; Hidalgo, MM; Arce, X. Acceptability and performance of the levonorgestrel-releasing intrauterine system IUD (Mirena) in Campinas. Contraception, 62:59-61, 2000.

Faúndes, A; Bossemeyer, R; Costa, RR; Codes, J. Planejamento familiar dentro do contexto de saúde sexual e reprodutiva. In: Andrade RP, Poli MEH, Petracco A, Morais KM, Camargos AF(eds.). Contracepção – Promoção da Saúde Sexual e Reprodutiva. Rio de Janeiro. Editora Revinter, 2000.p.13-25.
Faúndes, A; Faúndes, D. Anticoncepção hormonal com implantes subdérmicos. In: Pinho Neto, JS (ed.) Temas especiais de anticoncepção – FEBRASGO. Rio de Janeiro. Editora Revinter, 2000. p. 175-190.

Faúndes, D; Perdigão, A; Faúndes, A; Bahamondes, L; Petta, CA. T-shaped IUDs accommodate in their position during the first 3 months after insertion. Contraception, 62:165-168, 2000.

Petta, CA; Dantas, C; Hidalgo, MM & Bahamondes, L. Solicitações de reversão de laqueadura em um serviço de esterilidade: o problema continua. Reprod Clim, 15(4):214-217, 2000.

Bahamondes, L; Díaz, J; Petta, C; Monteiro, I; Monteiro, CD; Regina, CH. Comparison of the performances of the of Tcu 380A and Tcu 380S IUDs up to five years. Advances in Contraception, 15:275-281, 1999.

Bahamondes, L; Perroti, M; Castro, SRN; Faúndes, D; Petta, CA; Bedone, AJ. Forearm bone density in users of Depo-Provera as contraceptive method. Fertility and Sterility,71(5):849-852, 1999.

Díaz, M; Simmons, R; Díaz, J; Gonzales, C; Makuch, MY; Bossemeyer, D. Expanding Contraceptive Choice: Findings from Brazil. Studies in Family Planning, 30(1): 1-16, 1999.

Faúndes, A; Petta, CA; Lucas D’Oliveira, AF; Carneiro, LM; Souza, MJ; Costa, KS – A new scheme of diaphragm use: evaluation of its effectiveness and acceptance. Gynecological Endocrinology, 13(3):77, 1999.

Faúndes, A; Alvarez, F; Brache, V; Cochón, L; Tejada, AS; Moo-Young, A. Correlation of endocrine profiles with bleeding patterns during use of Nestorone® contraceptive implants. Human Reproduction, 14(12):3013-3017, 1999.

Faúndes, D; Neves, P; Petta, CA; Fazano, F; De Lucio, M; Ramos, M; Faúndes, A. Efficiency of different ovulation induction drugs in assisted reproduction. Gynecological Endocrinology, 13(3):39, 1999.
Osis, MJD. Esterilização e gravidez na adolescência: fatores inter-relacionados. In: Vieira, E. M. ; Fernandes, M.E. ; Bailey, P. ; Mckay, Ver (Org.). Gravidez na adolescência. Associação Saúde da Família. São Paulo. 1999. p.67-73.

Osis, MJD; Faúndes, A; Souza, MH; Bailey, P. Conseqüências do uso de métodos anticoncepcionais na vida das mulheres: o caso da laqueadura tubária. Cadernos de Saúde Pública 15(3):521-32, 1999

Bahamondes, LG; Maradiegue, E; Díaz, J; Trelles, J; Escanhoela C.; Petta C.A.; Arce, XE. Endometrial Histology in Long-Term Users of the Once-a-Month Injetable Contraceptive Cyclofem. Advances in Contraception, 15:1-7, 1999

Galvão, L; Díaz, J; Díaz, M; Osis, MJ; Clark, S; Ellertson, C. Emergency Contraception: Knowledge, Attitudes and Practices Among Brazilian Obstetrician-Gynecologists. International Family Planning Perspectives, 25(4):168-80, 1999.

Brache, V; Blumenthal, PD; Alvarez, F; Dunson, TR; Cochon, L; Faúndes, A. Timing of onset of contraceptive effectiveness in NorplantÒ Implante users II. Contraception, 59:245-51, 1999.

Hardy, E; Pádua, KS de; Osis, MJD; Jiménes, AL; Zaneveld, LJD. Women’s preferences for vaginal antimicrobial contraceptives IV – Attibutes of a formulation that would protect from STD/AIDS. Contraception, 58:251-5, 1998

Hardy, E; Pádua, KS de; Jiménes, AL; Zaneveld, LJD. Women’s preferences for vaginal antimicrobial contraceptives III – Choice of a formulation, applicator, and packaging. Contraception, 58:245-9, 1998

Hardy, E; Pádua, KS de; Jiménes, AL; Zaneveld, LJD. Women’s preferences for vaginal antimicrobial contraceptives II – Preferred characteristics according to women’s age and socioeconomic status. Contraception, 58:239-44, 1998

Hardy, E; Pádua, KS de; Jiménes, AL; Zaneveld, LJD. Women’s preferences for vaginal antimicrobial contraceptives I – Methodology. Contraception, 58:233-8, 1998

Faúndes, A; Costa, RG; Pádua, KSP; Perdigão, AM. Associação entre prevalência de laqueadura tubária e características sócio-demográficas de mulheres e seus companheiros no Estado de São Paulo, Brasil. Cad Saúde Públ, Rio de Janeiro, 14(Supl. 1):49-57, 1998.

Petta, CA; Faúndes, A; Dunson, TR; Ramos, M; DeLucio, M; Faúndes, D; Bahamondes, L. Timing of onset of contraceptive effectiveness in Depo-Provera users: Part I. Changes in cervical mucus. Fertility and Sterility, 69(2):252-7, 1998.

Petta, CA; Faúndes, A; Dunson, TR; Ramos, M; DeLucio, M; Faúndes, D; Bahamondes, L. Timing of onset of contraceptive effectiveness in Depo-Provera users: Part II. Effects on ovarian function. Fertility and Sterility, 70(5):817-820, 1998.

Alvarez, F; Brache, V; Tejada; AS; Cochon, L; Faúndez. Sex hormone binding globulin and free levonorgestrel index in the first week after insertion of NorplantÒ implants. Contraception, 58:211-4, 1998.

Faúndes, A; Alvarez, F; Brache, V; Cochón, L. Endometrial thickness and oestradiol concentration in women with bleeding complaints during use of NorplantÒ implants. Human Reproduction, 13(1):188-91, 1998

Faúndes, A; Telles, E; Cristofoletti, M de L; Faúndes, D; Castro, S; Hardy, E. The risk of inadvertent intrauterine device insertion in women carriers of endocervical Chlamydia trachomatis. Contraception, 58:105-9, 1998.

Faúndes, D; Bahamondes, L; Faúndes, A; Petta, CA. T-Shaped IUD move vertically with endometrial growth and involution during the menstrual cycle. Contraception, 57:413-5, 1998.

Gabiatti, JRE; Faúndes, A; Bahamondes, L; Faúndes, D; Ramos, M; Fazano, F. A experiência de iniciar um programa de fertilização in vitro em Hospital Universitário. +, 13(4);221-7, 1998

Hardy, E; Santos, LC; Osis, MJ; Carvalho, G; Cecatti, JG; Faúndes, A. Contraceptive use and pregnancy before and after introducing lactational amenorrhea (LAM) in a postpartum program. Advances in Contraception, 14:59-68, 1998.

Bahamondes, L; Lavin, P; Ojeda, G et al. Return of fertility after discontinuation of the once-a-month injectable contraceptive cyclofem. Contraception, 55:307-10, 1997.